CCCR [China Commercial Credit] DEF 14A: (Original Filing)
[]
IMOS [CHIPMOS TECHNOLOGIES BERMUDA] 6-K: (Original Filing)
[ChipMOS TECHNOLOGIES (Bermuda) LTD. By S. J. Cheng Chairman & Chief Executive Officer Contacts: In Taiwan Dr. S.K. Chen ChipMOS TECHNOLOGIES (Bermuda) LTD. +886-6-507-7712 s.k._chen@chipmos.com In the U.S. David Pasquale Global IR Partners +1-914-337-8801 dpasquale@globalirpartners.com ChipMOS REPORTS NOVEMBER 2015 REVENUE Hsinchu, December 10, 2015 Consolidated Monthly Revenues (Unaudited)]
CO [China Cord Blood] 6-K: China Cord Blood Corporation Announces Results of 201
[China Cord Blood Corporation Announces Results of 201 5 Annual General Meeting HONG KONG, China, December 10 , 201 5 - China Cord Blood Corporation At the Annual General Meeting, shareholders · · About China Cord Blood Corporation China Cord Blood Corporation is the first and largest umbilical cord blood banking operator in China in terms of geographical coverage and] [FORM 6-K 5 CHINA CORD BLOOD CORPORATION 48 th Floor, Bank of China Tower 1 Garden Road Central Hong Kong S.A.R. Form 20-F x o o o Yes o x Other Events On December 1 Description]
IMOS [CHIPMOS TECHNOLOGIES BERMUDA] 6-K: ChipMOS TECHNOLOGIES (Bermuda) LTD. By S. J. Cheng
[ChipMOS TECHNOLOGIES (Bermuda) LTD. By S. J. Cheng Chairman & Chief Executive Officer Contacts: In Taiwan Dr. S.K. Chen ChipMOS TECHNOLOGIES (Bermuda) LTD. +886-6-507-7712 s.k._chen@chipmos.com In the U.S. David Pasquale Global IR Partners +1-914-337-8801 dpasquale@globalirpartners.com ChipMOS REPORTS NOVEMBER 2015 REVENUE Hsinchu, December 10, 2015 Consolidated Monthly Revenues (Unaudited)]
CPHI [CHINA PHARMA] 8-K: (Original Filing)
[--------------- FORM 8-K CURRENT REPORT Date of Report (Date of earliest event reported): December 8, 2015 CHINA PHARMA HOLDINGS, INC. --------------------------------------- Nevada 001-34471 73-1564807 (State or other jurisdiction (Commission File No.) (IRS Employer of Incorporation) Identification No.) Second Floor, No. 17, Jinpan Road Haikou, Hainan Province, China 570216 +86 898-6681-1730 (China) Item 5.07 Submission of Matters to a Vote of]
QUNR [Qunar Cayman Islands] 6-K: (Original Filing)
[Qunar Receives Majority of Minority Shareholder Consent to Employee Share Exchange Program BEIJING, Dec. 9, 2015 (GLOBE NEWSWIRE) Qunar Cayman Islands Limited (NASDAQ:QUNR) (Qunar or the Company), Chinas leading mobile and online travel platform, today announced that, following Qunars announcement of an exchange program for its employees on October 26, 2015 and the managements voluntary undertaking to seek the] [QUNAR CAYMAN ISLANDS LIMITED Yilu Zhao]
CPHI [CHINA PHARMA] 8-K: ————— FORM 8-K CURRENT REPORT Date of Report
[--------------- FORM 8-K CURRENT REPORT Date of Report (Date of earliest event reported): December 8, 2015 CHINA PHARMA HOLDINGS, INC. --------------------------------------- Nevada 001-34471 73-1564807 (State or other jurisdiction (Commission File No.) (IRS Employer of Incorporation) Identification No.) Second Floor, No. 17, Jinpan Road Haikou, Hainan Province, China 570216 +86 898-6681-1730 (China) Item 5.07 Submission of Matters to a Vote of]
